VK 744

thieno-pyrimidine derivative with anti-platelet activity; RN given refers to parent cpd; structure

Also Known As:

2-(2-aminoethylamino)-4-morpholinothieno(3,2-d)pyrimidine dihydrochloride; VK 744 dihydrochoride; VK-744; N-(4-(4-morpholinyl)thieno(3,2-d)pyrimidin-2-yl)-1,2-ethanediamine, dihydrochloride

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrimidines: 510
    - VK 744: 2

Related Diseases

1.	Venous Thrombosis (Deep-Vein Thrombosis) 01/01/1975 - "Inhibitors of the platelet functions, collagen-induced aggregation and release reaction (ASA and sulfinpyrazone) and ADP-induced aggregation (dipyridamole and VK 744), were investigated as potential preventive agents against venous thrombosis formation in rabbits. "
2.	Thrombosis (Thrombus) 01/01/1978 - "Comparison of antithrombotic activity of heparin, ASA, sulfinpyrazone and VK 744 in a rat model of arterial thrombosis."

Related Drugs and Biologics

1.	Sulfinpyrazone (Anturane)
2.	Heparin (Liquaemin)
3.	Dipyridamole (Persantine)
4.	Collagen
5.	Adenosine Diphosphate (ADP)